Discover the optimal journal based on multiple criteria or locate authors along with their published articles and the corresponding journals.
Publisher
Subject Area
Open Acess
Quartille
Spectrum and Clinical Activity of PD-1/PD-L1 Inhibitors: Regulatory Approval and Under Development
HSD3B1 polymorphism in patients (pts) with metastatic castration-resistant prostate cancer (mCRPC) treated with abiraterone acetate and prednisone (AAP): Pharmacodynamics and therapeutic implications.
Predictive value of phase I trials for safety and final approved dose in later trials: Analysis of 33,845 patients.
Cardiovascular toxicity incidence following immune checkpoint inhibitors in randomized clinical trials: A systematic review and meta-analysis.
Bevacizumab as First-Line Therapy in Advanced Non-Small-Cell Lung Cancer
Mechanisms of resistance and sensitivity to anti-HER2 therapies in HER2+ breast cancer
